Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.24, $0.01 better than the analyst estimate of $0.23. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.86 billion.

Boston Scientific sees Q4 2015 EPS of $0.23-$0.25, versus the consensus of $0.26. Boston Scientific sees Q4 2015 revenue of $1.97-2.01 billion, versus the consensus of $2.00 billion.

Boston Scientific sees FY2015 EPS of $0.90-$0.92, versus the consensus of $0.91. Boston Scientific sees FY2015 revenue of $7.47-7.51 billion, versus prior guidance of $7.275-7.375 billion and the consensus of $7.48 billion.

For earnings history and earnings-related data on Boston Scientific (BSX) click here.